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Huang, Yan. M.S., Purdue University, December 2013. Interaction between Maltose 
Binding Protein and Escherichia Coli Maltose Transporter. Major Professor: Amy L. 
Davidson (late) and Jue Chen. 
 
The ATP-binding cassette (ABC) transporter superfamily is one of the largest 
families of transport proteins. The ABC transporters are responsible for selective 
permeability of solute across membranes energized by ATP hydrolysis, which occurs in 
all domains of life. Maltose transporter is an ABC importer that mediates 
maltose/maltodextrin uptake in bacteria and archaea. It is identified as an essential 
virulence factor in pathogenic species of Streptococcis pyogenes and Vibrio cholera (1, 
2). Escherichia coli maltose transporter is a well-characterized system with crystal 
structures and exclusive biochemical studies available. Knowledge of the E. coli maltose 
transport mechanism will lead to a better understanding of maltose transporters in the 
other species as well as other classes of ABC importers.  
The goal of this study was to characterize the mechanism by which the substrate 
binding protein stimulates the transport cycle. To study how MBP initiates the transport 
process, MBP was spin-labeled at a single residue of the N-lobe and the mobility 








second periplasmic loop of MalF, P2, was found to bind with MBP N-lobe throughout the 
catalytic cycle, suggesting that P2 is involved in the recruitment of MBP, as corroborated 
by previous studies. In addition, a lack of mobility change at the interface of the MBP N-
lobe and P2 suggested that the 5 Å decrease in the distance between MBP and MalF-P2 
upon addition of ATP or maltose from previous crosslink study is likely due to a rotation 
between MBP and P2. In comparison, maltose decreased the mobility between MalG P3 
and MBP at residue 41, suggesting that P3s’ conformation may be sensitive to maltose 
binding.  
Among the periplasmic loops of the transmembrane domains, the MalF-P2 loop 
shares an extraordinarily large interface with MBP N-lobe. It is possible that P2 has 
essential roles other than recruiting MBP. However, this is questioned by the fact that P2 
is missing in gram-positive and archaea maltose transporters. To test the functional roles 
of this region, P2 was truncated and the maltose transporter mutant without P2 was tested 
through in vivo maltose transport assays and then in vitro ATPase activity assay in 
nanodiscs. Results demonstrate that the interaction between P2 and MBP is essential to 
maltose transport. To further investigate the functions of P2, a P2-truncated mutant of a 
binding-protein independent mutant (F500) was constructed. The MacConkey assay 
result shows that this mutant can transport maltose in vivo, indicating that P2 is likely to 









CHAPTER 1. INTRODUCTION: STRUCTURE, FUNCTION AND DYNAMICS OF 
THE MALTOSE TRANSPORTER IN ESCHERICHIA COLI 
1.1 ATP-Bing Cassette (ABC) Systems 
The ATP-binding cassette (ABC) systems couple the energy of ATP hydrolysis to 
import and export molecules, as well as several non-transport-related processes including 
translation, elongation and DNA repair (3). Despite the diverse population of substrates 
and the difference in the direction of transport, ABC proteins share a common 
organization composed of two integral membrane domains and two peripheral ABC 
domains (4). The sequence and structure of the nucleotide-binding domain are highly-
conserved. ABC transporters play a significant role in both basic membrane biology and 
medical applications. In bacteria, ABC transporters are critical for survival; these proteins 
are targets for the development of antibacterial vaccines and therapies (5). In humans, 
several genetic defects in these proteins play a role in many diseases, such as cystic 











Figure 1.1 Structure of maltose transporter in a catalytic intermediate conformation. 
PBID is 3PV0 (6). Subunits are colored as indicated in the figure. 
 
1.2 Structure of the MBP-MalFGK2 Complex in E. coli 
E. coli maltose transporter is one of the most extensively-studied among all the 
ABC transporter systems. A pictorial representation of this system is given in Figure 1.1. 
The transmembrane domain (TMD) contains an intertwined heterodimer of MalF and 
MalG. Functional reconstitution of the subunits of E. coli maltose uptake system in vitro, 
the MalFGK2 complex, has been demonstrated successfully (7, 8). MalG of the E. coli 
maltose transporter is homologous to other species. The N-terminal periplasmic loop of 
MalF, the P2 loop, is large (approximately 180 residues), but, interestingly, it is unique to 
Enterobacteriaceae (9, 10). Although MalF TM 1 and TM 2 are usually missing in gram-









MalFGK2 structure or function (11). However, it is unclear whether truncation of P2 will 
affect the function of E. coli maltose transporter. Both MalF and MalG contain three 
periplasmic loops interacting with MBP and an EAA loop binding tightly with MalK (6). 
MBP is a periplasmic protein in E. coli but is usually a lipoprotein anchored to the 
membrane in gram-positive and archaea maltose transporter systems (9, 12).  
 
 
Figure 1.2 Structure of ATP-bound MalK Subunits (6). Left, the MalK dimer viewed 
down the local twofold axis. Right, the ATP-binding site, showing that Walker A and 
Walker B from one MalK subunit (green) and LSGGQ from the other MalK subunit (red) 
are making contact with one ATP molecule. ATP is represented in the ball-and-stick 
model. 
 
Similar to other ABC systems, the N-terminal domain of MalK contains a RecA-
like subdomain and a helical subdomain (Figure 1.2). The helical subdomain contains the 
LSGGQ motif, which is unique to ABC transporters. Like other bacterial ATP-binding 
cassettes MalK also has a C-terminal regulatory domain. This domain contributes 









ATP (13, 14), whereas other isolated cassettes behave as monomers without ATP. In the 
crystal structure (6), two ATP molecules are bound along the dimer interface contacting 
residues in the Walker A and B motifs of one MalK monomer and the LSGGQ motif of 
the other MalK monomer. 
The opening and closing motions of the MalK nucleotide-binding interface during 
ATP hydrolysis drive maltose across the membrane. Interestingly, these motions are 
demonstrated to be coupled to conformational changes of MBP and MalFG during the 
translocation cycle (15-18). The rate of maltose transport displays a sigmoidal 
dependence on the MBP concentration, with the half maximal uptake rate at about 25 to 
100 µM MBP (15, 16). In addition, ATPase activity of the MalFGK2 complex is strongly 
inhibited by vanadate; however, the isolated MalK is not (17, 18). The current progress in 
studying the coupling of maltose transport and ATP hydrolysis in the catalytic pathway 
will be introduced in the next section. 
 
1.3 Alternating Access Mechanism of the Maltose Transporter  
Three states of the catalytic cycle have been crystallized (6, 19, 20): (i) resting state, 
(ii) pretranslocation (pre-T) state and (iii) transition state (Figure 1.3). In the resting state 
(Figure 1.3A-B), MalK dimer interface is open and MalFG is facing inward to the 
cytoplasm (17, 21, 22). MalF P2 loop initially interacts with the N-lobe of MBP and 
assists MBP docking onto MalG. Upon the binding of maltose, MBP is stabilized in the 












Figure 1.3 Alternating access mechanism of the maltose transporter (19, 23, 24). (A, B) 
Resting state: MalK interface is open, MalFG is facing inward and MBP is stabilized in 
the closed conformation after binding maltose. (C) Pre-T state: MalK interface is semi-
open, MalFG is in an intermediate conformation between inward- and outward- facing, 
and MBP is binding tightly with MalFG. (D) Transition state: MalK interface is closed, 
MalFG is facing outward and MBP is open, and maltose is translocated to the binding site 
of MalFG. (D-A) After ATP hydrolysis, the MalK dimer interface opens and MalFG is 
reoriented to the inward-facing conformation, releasing maltose into the cell. The lower 
panel shows slab views of the maltose transporter in resting state (left), pre-T state 










In the pre-T state (Figure 1.3B-D), the MalK dimer interface is semi-open, MalFG 
is in an intermediate conformation between inward- and outward- facing, and maltose-
bound MBP has a tight binding with MalFG. In the absence of MBP, the resting state 
transporter displays little ATPase activity, indicating that there is a high energy barrier in 
the progression from inward- to outward-facing conformations that ATP binding alone 
cannot overcome (3, 22, 25). An intermediate conformation of MalFGK2 was captured by 
the “pre-T” crystal structure. This intermediate conformation is supposed to be of high-
energy since the partial closure of the MalK dimer interface can promote to a fully closed 
transition state by the addition of Mg ion and the non-hydrolysable ATP analog AMP-
PNP (19, 25). The detailed mechanism of how the transporter converts from resting state 
to pre-T is not yet clear. MBP or nucleotide alone does not trigger the conformational 
changes from resting state to transition state (3, 22). The pre-T crystal structure reveals 
that MalFGK2 can convert to the pre-T state with maltose and MBP in the absence of 
ATP, and can proceed to the transition state by the addition of Mg ion and the 
nonhydrolysable ATP analog, AMP-PNP. However, the EPR studies showed no mobility 
changes for the four single spin mutations labeled at Q-loop (S83C), or the helical 
subdomain (V120C, Q122C, and A124C) of MalK in the intact transporter following the 
addition of either maltose-bound MBP or Mg-AMP-PNP alone(22). The EPR data are not 
necessarily inconsistent with the crystal structure since it only indicates no binding or 
opening at the dimer interface but may not show rotation motions of the MalK dimers. It 
is likely that MalK dimers rotate toward a partial closure in the presence of maltose-









In the transition state (Figure 1.3D), the MalK dimer interface is closed and ATP(s) 
is positioned at the catalytic site for hydrolysis. MalFG turns out-ward facing while MBP 
is open, allowing maltose to translocate into the low-affinity binding site in MalFG. 
Radioactive elution profile of the vanadate trapped complex showed that MBP is tightly 
bound with MalFG and that maltose is not bound tightly by MBP in the vanadate-trapped 
species. Consistently, the crystal structure of the transition state showed that the open 
MBP co-crystallizes with the transporter and maltose locates at the MalFG binding site (6, 
19). The crystal structure of MalFGK2 with wild-type MBP converts from the pre-T state 
to the transition state when Mg and AMP-PNP are added. In contrast, the pre-T state 
MalFGK2 with the crosslinked MBP mutant that is locked in the closed conformation 
cannot proceed to the transition state by the addition of Mg ion and AMP-PNP (19). 
Therefore, the high affinity of open MBP with MalFGK2 in the vanadate-trapping 
transition state indicates that open MBP may play a key role in stabilizing the outward 
facing conformation of MalFG (6, 19, 26). Theoretically, unliganded MBP should not 
convert the open MalK dimer to closed dimer conformation. However, experimental data 
has shown a weak stimulation of unliganded MBP on ATP hydrolysis. This is likely to be 
due to a very small population of transporters that engage in high-affinity binding with 
the open MBP and progress far enough toward the transition-state conformation (27). 
Although a posthydrolysis state of the entire transporter is yet to be crystallized 
(Figure 1.3D-A), EPR studies and analysis of the isolated NBD structures suggest that 
ADP is not sufficient to stabilize the closed dimer conformation (17, 21, 22). Thus, MalK 









inward-facing conformation, releasing the substrate from the low-affinity TMD binding 
site into the cell through diffusion (Figure 1.3) (28).  
The studies on mutations of the transporter comparing the ATPase activities of the 
intact transporter and those of the isolated MalK dimers provides more detailed 
information on sites possibly involved in the coupling between MalK and MBP. The 
stimulatory effect of MBP on the ATPase activity of the intact transporter is prevented by 
the mutation of residue Q140 following the LSGGQ motif while the ATPase activity of 
isolated MalK is not affected by MBP, suggesting a role of the LSGGQ motif in the 
communication between MBP and MalK (21). The P2 (second periplasmic) loop of MalF, 
the first periplasmic (P1) loop of MalG and the EAA loop of MalG were reported by 
mutation suppressor studies to be involved with the communication between MBP and 
MalK (28). Researchers have sought to unveil the mystery of this coupling between 
substrate translocation and ATP hydrolysis through isolation and analysis of the binding 
protein-independent (BPI) mutants of the maltose transporter, as described in the next 
section. 
 
1.4 Binding Protein-Independent (BPI) Mutants 
Binding protein-independent (BPI) transporters can transport maltose into the cell 
independently of MBP (29, 30). A pictorial presentation of BPI in comparison with wild-
type maltose transporter is given in Figure 1.4A. BPI mutants are similar to the wild-type 
in terms of maltose-specificity, as well as the affinity, cooperativity, vanadate sensitivity, 
and  substrate specificity of the ATP binding sites (25, 30, 31). Genetic analysis shows 









transmembrane helix while the other is located in a periplasmic loop which exposes the 
maltose binding site of the transmembrane domain to the periplasm and perturbs the 







Figure 1.4 A binding protein (BPI) mutant of the maltose transporter. (A) Model for BPI 
maltose transport (31). (B) Structure of the maltose transporter (PBD ID: 3PV0) with 
sites of the BPI mutation F500 labeled (MalF G338R and N505I). The sphere in red is 
G338 at MalF. The sphere in grey is N505 at MalF C-terminus. Color codes: purple, 
MBP; yellow, MalF; cyan, MalG; red and green, MalK dimer.    
 
MBP was found to have an effect on the BPI catalytic cycle different from that of 











maltose transport and ATPase activity of the wild-type maltose transporter keep increase 
and then go flat when MBP concentration is saturated. In contrast, higher concentration 
of MBP (>1mM) severely inhibits maltose transport of BPI, perhaps because MBP fails 
to separate from the BPI, or it shifts MalK to an open rather than a closed conformation 
while bound maltose are not delivered to the membrane binding site (32, 33). However, 
in some BPI mutants such as MalG511 MalFGK2 transporter, MBP at lower 
concentrations still stimulates maltose transport (34). Efforts have been made by 
researchers on a better understanding of the mechanism of the BPI mutants in order to 
gain us more knowledge on the mechanism of the wild-type transporter.  
Different statements about the resting conformation of BPI can potentially explain 
the working mechanism of BPI. One explanation is that the transporter rests in an 
outward-facing state which exposes the low-affinity transmembrane maltose binding site 
to the periplasm (35). This is based on the identical protease susceptibility data of BPI 
periplasmic loops of MalF and MalG and of the transition-state maltose transporter 
mutant (MalKE159Q) MalF and MalG (35). A more rational explanation is that BPI rests 
in a high-energy intermediate state which can easily proceed to the transition state in the 
presence of nucleotide (19, 25). Fluorescence data supportive to this explanation showed 
that the accessibility of the BPI ATP-binding site is less than that of the wild-type 
transporter at resting state and similar to the wild-type transporter in the presence of MBP 
and vanadate (36).  
Based on these findings, we assume that the double mutations of BPI drives the 
majority of the MalK domains to rest in a semi-open conformation that favors proceeding 











overcome the energy barrier of a shift from open to semi-open conformation. Maltose can 
also enter the MalFG binding site because the site is exposed to the periplasm. F500 is 
one of the BPI mutants with mutations of MalF G338R and N505I (Figure 1.4B). F500 
was used in this work on the function of P2 by constructing a P2-deleted mutant of F500 












CHAPTER 2.  EXPERIMENTAL PROCEDURES 
2.1 Mutagenesis 
The Quikchange II XL site-directed mutagenesis kit (Stratagene) was used to 
generate single mutations in the variants of the malE gene encoding MBP with a C-
terminal polyhistidine tag (37). We constructed the double mutants of malF by two steps 
of single mutation with the PCR machine and PfuUltra II Fusion HS DNA Polymerase 
and then digested with DpnI. The sequences of the mutant genes were verified by DNA 
sequencing. Dr. Michael Oldham replaced 164 residues (94 to 257) of MalF-P2 in the 
maltose transporter by a short linker of GSGSG, and the mutant is named MalF(ΔP2)GK2 
(figure 2.1). In vivo function of the mutant proteins was confirmed by complementation 
of a chromosomal deletion of malE, malF, malG, malK (strain AD126 (argH his rpsL1 
malTc, malB∆13 ∆uncBC ilv::Tn10, F'lacIq Tn5), as judged on 1 % maltose MacConkey 
agar (Difco) (38). Plasmid-encoded mutants that are functional yield colonies that turn 












Figure 2.1 Diagram of the secondary structure of MalF (blue) with P2 highlighted in red 
square. The amino acid residues 94-257 of MalF-P2 are replaced with GSGSG (6). 
 
2.2 In vivo maltose transport assay: MacConkey assay 
MacConkey plates were prepared by autoclaving MacConkey agar and then 
supplementing with 1% maltose and antibiotics. E. coli strain AD126 carrying a genomic 
deletion of malE, malF and malG, was transformed with plasmids encoding different 
combinations of the wild-type or mutant E. coli maltose transporter components. The 
cells of the transformed strains were then spread on MacConkey plates. Colonies were 
observed after incubations of either 12 hours or 14 hours at 37 °C. Red and white 












2.3 Expression and Purification of Proteins 
2.3.1  Expression and Purification and Assembly of MalFGK2 Complex 
MalF, MalG and MalK were overexpressed simultaneous with two plasmids in the 
strain AD126 (argH his rpsL1 malT
c
 malB∆13 ∆uncBC ilv::Tn10 F'lacI
Q
 Tn5) which 
carries the deletion of F0-F1 ATPase. Then the three subunit proteins were overexpressed 
and co-purified as a complex (MalFGK2) by affinity chromatography using a 6×histidine 
tag attached to the C-terminus of MalK as described previously (6). The modification of 
the protocol is that the cell pellet resuspension buffer contains 20 mM Tris (pH 8.0), 5 
mM MgCl2, 10% glycerol, and 0.4% n-Dodecyl-β-D-Maltopyranoside (DDM, Anatrace). 
Extracted MalFGK2 was purified on cobalt Talon resin (Clontech) in buffer containing 20 
mM Tris (pH 8.0), 100 mM NaCl, and 0.015% DDM. The eluted fractions were dialyzed 
overnight at 4°C to remove imidazole and then followed by size-exclusion 
chromatography (Superdex 200, GE Healthcare). Proteins were concentrated with a 
Millipore filter with 100 kDa cut-off and stored in -80°C until ready for use.  
 
2.3.2  Expression, Purification and Spin Labeling of MBP 
Wild-type or mutant MBP was cloned into pMCSG7 LIC vector, which encodes a 
10xHis tag at the N-terminus of the protein, and then expressed in the E. coli strain 
BL21(DE3) Star. Cells were grown in Luria-Bertani medium at 37°C to the 
midexponential phase and then the overexpression of MBP was induced by isopropyl-d-
thiogalactoside at 22°C for 20 hours. MBP was purified by cobalt-affinity 
chromatography in buffer containing 20 mM Tris-HCl pH 8.0 and 150 mM NaCl (2mM 











Healthcare) chromatography in buffer containing 10 mM Tris-HCl pH 8.0, 200 mM NaCl. 
To spin label the cysteine mutants of MBP (residue 41 and 271), 1 mL of a 200 µM 
solution of purified MBP was pretreated with 200 µM DTT to break any non-
physiological MBP dimers formed due to the oxidizing environment of the cobalt affinity 
resin, then incubated with 2 mM MTSL and 500 µL nickel-Sepharose 6 Fast Flow resin 
(GE Healthcare) overnight with gentle shaking at 4°C. The resin was collected in a 
column, washed with a buffer containing 20 mM Tris-HCl at pH 8.0 with 100mM NaCl 
and 1mM EDTA to remove excess spin label.  
 
2.3.3  Expression, Purification, and Removal of Histidine-tag of Membrane Scaffold 
Protein (MSP) 
Expression and purification of a Membrane Scaffold Protein (MSP) for 
reconstituting nanodiscs with a diameter of 12.1 nm were performed as described 
before(39). In brief, the plasmid (pMSP1E3D1; Addgene) encoding for a polyhistidine-
tagged MSP with TEV protease cleavage site at the N-terminus was transformed into E. 
coli strain BL21(DE3). 50ml of LB medium supplemented with 30 μg/mL kanamycin 
was used to grow cells. Till OD600 reached 0.6, the entire culture was transferred into a 
500 mL TB medium (plus 30 μg/mL kanamycin) in a 2L flask.  The culture was 
incubated at 37 °C, induced by 1mM IPTG isopropyl β-D-1-thiogalactopyranoside (IPTG) 
when the OD600 reached 2.5-3.0, and then centrifuged at 4,000 x g for 15 min at 4 °C. 
The cell pellet was resuspended in 30 mL of  20 mM sodium phosphate buffer with pH of 
7.4 containing 1 mM phenylmethylsulfonyl fluoride (PMSF, Sigma), 1% Triton X-100 











resuspension through a high-pressure homogenizer (Emulsiflex-C5; Avestin) at 
1500~2000 psi. Cell debris was removed by centrifugation at at 80,000 x g for 40 min at 
4 °C. The supernatant was mixed with pre-equilibrated Ni Sepharose 6 Fast Flow resin 
(GE Healthcare), for 1 hour with gentle rocking at 4 °C. Then the mixture was loaded 
into a column, allowing the liquid to flow through, followed by 1) 10 column volume 
(CV) washes of Tris/HCl 40 mM pH 8, NaCl 0.3 M, Triton X-100 1%; 2) 5 CV washes 
of Tris/HCl 40 mM at pH 8, 0.3 M NaCl, 50 mM sodium cholate, 20 mM imidazole; and 
3) 7 CV washes of  40 mM Tris/HCl at pH 8, 0.3 M NaCl, and 50 mM imidazole. MSP 
was eluted with 40 mM Tris-HCl at pH 8.0, 300 mM NaCl, and 400 mM imidazole. To 
store the uncut MSP, it was first dialyzed against 3.5 L of buffer A (20 mM Tris/HCl at 
pH 8 and 100 mM NaCl) at 4 °C and then frozen in -20°C. To cleave the N-terminus his-
tag, before dialysis, MSP was incubated with TEV in the presence of 5 mM β- 
mercaptoethanol overnight and be passed through cobalt-affinity column to remove TEV 
protease and uncleaved MSP. 
 
2.4 Reconstitution of MalFGK2 in Nanodiscs 
Nanodiscs represent a more native environment than liposomes, detergent micelles 
or bicelles and allow the study of purified membrane proteins with many techniques 
including size-exclusion chromatography, electron paramagnetic resonance, and 
analytical ultracentrifucation. Nanodiscs are soluble disk-shaped membrane patches. 
They contain a phospholipid bilayer encircled by a membrane scaffold protein. The 
MalFGK2 was shown to recover its MBP-dependent ATP hydrolysis with little to no 











represent alternative reconstitution systems for MalFGK2, reconstitution in nanodiscs is 
more convenient than in bicelles and it is suitable for studying the transporter using size 
exclusion chromatography and electron paramagnetic resonance spectroscopy.  
The nanodiscs were prepared using a certain ratio of soybean phospholipids: MSP: 
maltose transporter specified in corresponding sections. Cholate was added to solobilize 
the lipids. The final concentration of cholate was 25 mM, which is well above its critical 
micelle concentrations. The solubilized lipids, DDM-stabilized MalFGK2 and purified 
MSP were mixed in a final volume of 250 μL in a microcentrifuge tube. The final 
concentrations of the maltose transporter and glycerol were 6 ~15 μM and < 3%, 
respectively. The assembly mixture was allowed to equilibrate for 1 hour at room 
temperature with gentle rocking. Then pre-washed biobeads SM-2 (BioRad) were 
dehydrated by vacuuming and were incubated with the mixture for 3 hours at room 
temperature with gentle rocking to trigger self-assembly of the nanodiscs by detergent 
removal. Then the bottom of the microcentrifuge tube was pierced. With a new 
microcentrifuge tube collecting the eluate, the microcentrifuge tube containing the 
mixture was spun at 1,000 ×g to separate the nanodiscs from the biobeads. Finally, the 
sample was spun at 10,000 ×g to remove any precipitates.  
 
2.5  Size Exclusion Chromotography  
The procedures of size-exclusion chromatography conducted in section 4.4 are 
described in (33). Samples (10 µL) in Buffer A were passed through a pre-equilibriated 
Superdex 200 5/150 size exclusion column (GE Healthcare) at room temperature at a 











volume was at 1.0 mL. The protein standards (Biorad) were (kDa): 670, 158, 44 and 17, 
which gave the following retention volumes (mL): 1.12, 1.56, 1.89 and 2.18, respectively.  
The procedures conducted in other sections are described as the following. 
MalFGK2 in buffer containing 20 mM Tris (pH 8.0), 100 mM NaCl, and 0.015% 
DDM.were passed through a Superdex 200 10/60 size-exclusion column and MBP in 
20mM Tris-HCl 150mM NaCl buffer (pH 8) were injected into the Superdex 75 10/60 
(for MBP) size-exclusion column (GE Healthcare). The column runs at 4°C at a flow rate 
of 1 mL/min using an AKTA purifier chromatography system. 
 
2.6 ATPase Activity Assay 
A coupled ATP-regeneration system was used to measure the ATPase of the 
maltose transporter complex as described in (3). Briefly, besides the maltose transporter, 
the ATPase activity assay solution consists of 50 mM Hepes/KOH at pH 8.0, 10mM 
MgCl2, 4 mM phosphoenol pyruvate, 60 μg/ml pyruvate kinase, 32 μg/mL lactate 
dehydrogenase, 0.3 mM NADH and 1.5 mM ATP, in presence or absence of 150 μM 
maltose or MBP. The concentration of MBP will be specified in the later sections. 
Typically, 1 μg maltose transporter in nanodiscs assembly was added to a final volume of 
70 μL for the assay. The amount of MalF(ΔP2)GK2 mutant used in the assay is 10 μg. A 
5-min preincubation of the sample with ATPase activity assay reagents at room 
temperature was employed prior to the addition of ATP. The ATPase activity was 
measured at room temperature. Activity was reported as μmol of ATP 












2.7 Electron Paramagnetic Resonance (EPR) 
X-band continuous wave (CW) EPR spectroscopy was carried out on a Bruker 
EMX-plus fitted with an ER4119HS cavity using WinEPR v4.40 as the computer 
interface. Sample volume was 30μl. The spectra were recorded at room temperature using 
10 mW microwave power and 100 kHz modulation amplitude over 1.0 Gauss (G). Nine 
times over a 100 G scan width will be used. The spectra will be normalized to the same 
number of spins, calculated using Bruker WinEPR Processing, as the normalized double 
integral of the signal. 
 
2.8 Analytical Ultracentrifugation (AUC) 
The sedimentation coefficient, s, is described by the Svedberg equation:  
  
 
   
 
      
  
 
Where ν is the velocity of the molecule, ω2r is the strength of the centrifugal field, 
M is the molecular mass, f is the frictional coefficient (which is directly related to 
macromolecular shape and size), ρ is the density of the solvent, N is Avogadro’s number, 
and   is the partial specific volume of the solute.  
 In a high-speed sedimentation velocity experiment, the solute moves away from 
the air-solvent interface (i.e. the meniscus) to the bottom of the cell and forms a solute 
concentration gradient, named the boundary. The boundary sediments and diffuses with 
time and displays “boundary spreading” over the course of the experiment. The 
combination of the sedimentation and diffusion in the ultracentrifuge cell is described in 












where D is the diffusion coefficient, c is the solute concentration, and ∂c/∂r is the solute 
concentration gradient. In theory, the sedimentation velocity experiments can determine s 
and D (which is proportional to f). In the proposed research, M and D of the molecules 
are known. Considering two proteins with similar shape and size, the greater the 
molecular mass is, the bigger the sedimentation coefficient will be.  In addition, 
concentration is positively correlated with UV280 which is detected during spinning. 
Given the relation of UV280 absorption versus s, we can quantify the amount of the 
nanodiscs of MalFGK2 bound and unbound with MBP and finally plot the binding curve 
to obtain the dissociation constant. 
 
2.9 Intrinsic Fluorescence Binding Assay 
The binding assay is done in a fluorometer excited at 280nm, emitting at 344nm 
(41). The volume of the cuvette is 3mL. It is assumed that both gal-glu4 and MBP have 
1:1 binding to MBP. The data are fitted with the equation (42): 
f = [L]free / (Kd + [L]free) 











CHAPTER 3. INITIAL INTERACTION BETWEEN MBP AND MALFG 
3.1 Introduction 
Usually, ABC transporters share a feature of substrate-bound binding protein 
(importers) or substrate (exporters) stimulation of the transporter ATPase activity, thus 
avoiding futile cycles of ATP hydrolysis and optimizing substrate transport efficiency. As 
an extensively-studied example, maltose transporter can be stimulated by maltose-bound 
MBP up to several-thousand fold. However, like other ABC transporters, the mechanism 
by which MBP stimulates the maltose transport is unclear.  
MBP consists of two lobes, a C-lobe that contacts MalF and an N-lobe that binds 
MalG and the MalF-P2 loop (Figure 3.1). Previous EPR studies on C-lobe MBP in our 
lab (33, 43) have shown spectral broadening by EPR when maltose was added into the 
MalFGK2 nanodiscs and spin-labeled MBP 41C/211C sample, indicating that maltose 
triggers MBP closure. However, how MBP first interacts with the transporter and why 
MBP stimulates ATP hydrolysis better with maltose than without remains unclear. Our 
hypothesis is that maltose enhances the interaction between MBP and maltose transporter. 
To test, the three interface regions between MBP and MalFG will be investigated by 











Figure 3.1  Three regions of interface between MBP and MalFG. A ribbon diagram (left) 
and a slab view (right) of the interacting regions between MBP (magenta) and MalF (blue) 
as well as between MBP and MalG (yellow) in the crystal structure (PBD ID: 3PV0). The 
interfaces are highlighted in red circles.  
 
3.2 Initial interaction between MBP N-lobe and MalF-P2 
To test the interaction between MBP N-lobe and MalF-P2 throughout the catalytic 
cycle, a cysteine mutant of MBP (MBP E274C) at the interface of P2 and MBP N-lobe 
was prepared for the EPR experiment. The MBP E274C mutant exhibited an in vivo 
transport positive phenotype on MacConkey agar with 1% maltose, suggesting that this 
mutant is able to uptake maltose. Spin-labeled MBP E274C was concentrated to 60 μM 
and stepped through the maltose transport cycle by successively adding 120 μM 
MalFGK2 and the ligands as reported before (43). Ficoll alone was added to MBP 
mutants to simulate a decrease in the rate of tumbling that MBP would experience 















Figure 3.2 Interaction of MTSL-modified MBP E274C with MalFGK2. (A) Location of 
MBP E274 in the maltose transporter (PBD ID: 3PV0). Colour codes: magenta, MBP; 
yellow, MalF; cyan, MalG; red and green, MalK dimer. MBP E274 is shown in an 
enlarged view in darker magenta. (B) The interaction with MalFGK2 and the effect of 
maltose ligands. The small picture on the right shows the effect of Ficoll. MBP E274C 
was present at 50 μM and MalFGK2 was stabilized in nanodiscs at 100 μM. The buffer 
contains no NaCl. EPR spectra are 100G wide. They are color coded according to the 
ligands, overlaid and normalized to the same number of spins. 
 
The spectrum of MBP E274C and FicoII is very similar to that of MBP274C alone 











MalFGK2 stabilized in nanodiscs results from the binding of MBP to MalFGK2 instead of 
a change in the rate of molecular tumbling. Subtraction of the unbound MBP from the 
composite spectrum allowed us to estimate that 72% of MBP was bound to the 
transporter. There was little difference in the height of the immobile shoulder (see arrow) 
throughout the catalytic cycle by adding ligands, which suggests that there was little 
difference in the fraction of MBP bound with the transporter throughout the catalytic 
cycle. No change in the immobility was detected from the spectra upon the addition of 
maltose. This implies that maltose does not change the binding or conformation at the 
interface of P2 and MBP N-lobe. In addition, a slight increase in the immobility shoulder 
was observed upon the addition of ATP and EDTA, suggesting a more stable binding of 
P2 and MBP at the ATP-bound transition state (6). Addition of Mg
2+
 ion and ATP 
promoted ATP hydrolysis by MalFGK2, followed by a return of the MBP E274C 
spectrum to overlap with that of maltose-bound MBP and MalFGK2 alone. 
 
3.3 Initial interaction between MBP N-lobe and MalG 
To investigate the initial interaction between MBP N-lobe and MalG, site 41 of 
MBP was mutated into cysteine and labeled for EPR. The MacConkey assay showed that 
the MBP D41C mutant supports maltose transport in the presence of the maltose 
transporter. Then the spin-labeled MBP D41C was concentrated to 60 μM for EPR 
experiments with MalFGK2 in detergent and reconstituted in nanodiscs and the results 
were consistent.  
The increase of viscosity by FicoII in the sample of MBP 41C and maltose did not 










change in the spectrum shoulder is caused by the more immobile environment of the 
backbone near the spin label site.  
Upon the addition of MalFGK2, the shoulder in the spectrum of MBP41C + 
maltose increased. When the spectrum of the MBP D41C mutant with maltose and 
MalFGK2 was compared with the spectrum of the MBP D41C mutant with maltose alone 
(Figure 3.2B), it was clear that addition of MalFGK2 resulted in a two-component 
spectrum. The more mobile component appeared to correspond to the unbound MBP, 
whereas the less mobile component (indicated with an arrow) corresponded to MBP 
bound to MalFGK2 at the interface of MalG and MBP. It was estimated that 89% of the 
MBP was bound to MalG based on the subtraction of the unbound MBP from the 
composite spectrum. Addition of Vanadate Mg-ATP to mimic the transition state causes 
the percent bound MBP to increase to about 96% (6). The EPR spectra of MBP D41C 
and MalFGK2 in nanodiscs in the presence or absence of maltose were compared (Figure 
3.2C). A decrease in the mobility was observed upon the addition of maltose, indicating 















Figure 3.3 Interaction of MTSL-modified MBP D41C with MalFGK2. (A) Location of 
MBP D41 in the maltose transporter (PBD ID: 3PV0). Colour codes: magenta, MBP; 
yellow, MalF; cyan, MalG; red and green, MalK dimer. MBP D41 is shown in an 
enlarged view in darker magenta. (B) The interaction of MBP41C with MalFGK2 and the 
effect of maltose ligands. The small picture on the right shows the effect of Ficoll. MBP 
E41C was present at 50 μM and 100 μM MalFGK2 was stabilized in 0.01% DDM. (C) 
The effect of maltose on 50 μM MBP41C and 100 μM MalFGK2 stabilized in nanodiscs. 
The buffer in (B) and (C) contains no NaCl. EPR spectra are 100G wide and are overlaid 
with colors that are coded according to the ligands added. EPR spectra in (B) are 
normalized to the same number of spins while spectra in (C) are normalized to the 
maximum amplitude. 
 
In agreement with literature, the signal of the immobile component increased 













docks onto the transporter and changed the mobility at site 41 (43). However, the percent 
of MBP bound in Figure 3.2B is higher than that reported in the literature (about 89% 
versus 60%). A viable explanation for this discrepancy is the different concentrations of 
MBP and the transporter used.  
In contrast to the decrease in mobility upon addition of maltose in Figure 3.2C, 
previous literature showed that no significant change in the mobility at position 41 upon 
the addition of maltose to MBP41C and MalFGK2 (43). The possible explanation is that 
NaCl concentration is different. The buffer in this study contained no NaCl whereas the 
buffer in previous studies contained 150mM NaCl. The higher concentration of NaCl 
likely weakened the electrostatic interaction between MBP and the transporter to such an 
an extent that the interaction signal was not detected.  
 
3.4 Initial interaction between MBP C-lobe and MalF 
In the previous two sections, initial interaction between two regions of MBP N-lobe 
and MalFG were reported. This section reports on the interaction between MBP C-lobe 
and MalF. The EPR experiments on MBP C-lobe was majorly performed by Dr. Frances 
J.D. Alvarez (45). I helped her do some of the experiments. 
The spectra of MBP 345C changed similarly slightly upon the addition of 
transporter as upon the addition of 20% Ficoll. In addition, no obvious difference was 
observed upon the addition of maltose. These suggested that the majority of MBP C-lobe 
does not dock onto the maltose transporter without nucleotide. Different from our EPR 











A rational explanation for this difference is that MBP is in equilibrium between 
association and dissociation with the maltose transporter and crystal structure can only 
represent the one conformation that favors crystal packing. In contrast, EPR is able to 
represent real equilibrium in its natural environment. These can be supported by the fact 
that the pre-translocation complex cannot be co-purified by gel purification, probably 
because of weak binding between MBP and the maltose transporter in the presence of 
maltose alone. This suggests that the pre-translocation crystal structure is not the most 
stable conformation in solution. 
 
Figure 3.4 Interaction of MTSL-modified MBP 345C with MalFGK2. Left, the 
interaction of MBP 345C with MalFGK2. Right, the effect of Ficoll on the ERP spectra of 
MBP 345C. The EPR spectra are 100G wide and are overlaid. EPR spectra in are 
normalized to the same number of spins. MBP was present at 60 µM and MalFGK2 at 
120 µM. Ligands were added at the concentrations specified in chapter 2. All 
experiments with MalFGK2 present were performed in detergent (DDM) solution.  The 
spectra recorded without (black) or with (grey) maltose are overlaid.  
 
3.5 Discussion 
Previous studies reported the importance of periplasmic regions in MBP-
stimulated maltose transport by showing that three mutations on these loops partially 
restore transport of a maltose-negative mutant (MalK Q140K) that was impaired in MBP-
stimulated ATPase activity (28). Among these periplasmic loops, P2 is unique to 










crosslinking studies (24, 47), we found that P2 is in close contact with MBP N-lobe 
throughout the catalytic cycle (Figure 3.1B), suggesting P2 is important in recruiting of 
MBP.  
Maltose induces a more immobile interaction between MalG and MBP at site 
41(Figure 3.2C). P3, a loop of MalG, is one periplasmic loop at the interface of MBP N-
lobe and MalG, which was demonstrated to be important in substrate translocation from 
MBP to MalFG by “scooping” maltose out of the MBP maltose binding site and blocking 
the rebinding of maltose to MBP (48). The increase of immobility at the interface of P3 
and MBP might result from a conformational change of P3 upon the addition of maltose 
and thus we suspect that MalG-P3 might be sensitive to substrate binding. In addition, in 
agreement with the vanadate trapping studies (26), the increase in immobility at both site 
274 and 41 suggests a more stable binding of MBP and MalFGK2 at transition state 
(Figure 3.1B and Figure 3.2B).  
In summary, three regions of MBP were spin-labeled and the spin label mobility 
was studied. MBP N-lobe interacts with MalF-P2 throughout the transport cycle; mobility 
decreases upon the addition of maltose at the spin label site of 41 suggesting stronger 
interaction between MBP N-lobe and MalG; mobility did not change significantly at the 
spin label site 345 indicating no significant change in interaction between MBP C-lobe 
and MalF. These suggest that maltose enhances initial interaction between MBP and the 
transporter by promoting N-lobe interaction, which explains why maltose-bound MBP 
stimulates transporter more efficiently than maltose-free MBP. Although P2 maintains a 
close contact with MBP N-lobe throughout the catalytic cycle, the exact role of P2 is 











CHAPTER 4. FUNCTIONAL STUDY OF MALF-P2  
4.1 Introduction 
In literature, it was reported that isolated P2 can fold independently of the 
transporter complex and the P2-MBP dissociation constant determined by isothermal 
titration calorimetry experiments is on the order of 10-20 μM, similarly in the presence or 
absence of maltose (47). Since the binding affinity of the intact maltose transporter is also 
in the micromolar range, the authors proposed that P2 is sufficient to bind MBP (47). 
Recently, further investigation was reported on the effect of isolated P2 on MBP (49). A 
third conformation is adopted by the maltose-bound MBP in the presence of P2 that is 
distinct from the closed maltose-bound MBP and open maltose-free MBP (49). Increased 
solvation rates for residues in the substrate-binding pocket were observed upon the 
addition of P2 by solvent-PRE measurements, further indicating a change in the solvent 
accessibility of the maltose-binding cleft in the presence of P2 (49). These data indicate 
that a possible third conformation of MBP induced by P2 could be a semi-open 
conformation which might play an important role in the activation of substrate transport 
by stabilizing the complex during the catalytic cycle. However, due to the lack of other 
contact interfaces between MBP and MalFG, the interaction between the isolated P2 and 
MBP may not work the same way as when it is part of the intact maltose transporter. 











shorter and are missing in homologous systems from Gram positive bacteria and archaea, 
where MBP is tethered to the membrane. Therefore, it is likely that P2 in the actual 
complex of maltose transporter in E. coli may function differently from the study of 
isolated P2. The EPR studies in Chapter 3 have demonstrated that P2 is important in 
recruiting MBP and MBP movement. To test whether P2 has additional important 
functions, a truncation that replaces P2 with a short GSGSG linker was constructed in 
both the wild-type maltose transporter and one BPI maltose transporter to carry out in 
vivo and in vitro assays. The linker is for the purpose of maintaining the natural structure 
of the maltose transporter after deleting P2 by linking the two segments of MalF. 
4.2 Effect of P2 truncation on Maltose Transport In Vivo 
Maltose transport of the P2-deleted maltose transporter mutant MalF(ΔP2)GK2 
(section 2.1) was tested by in vivo MacConkey assay. We showed that the mutant exhibits 
an in vivo transport negative phenotype on maltose MacConkey agar (Table 4.1). This 
indicated that deletion of P2 prevents maltose transport in E. coli. This agrees with 
previous report on the maltose uptake deficient phenotype of four MalF-P2 mutants (46), 
which indicated that P2 is necessary for maltose transport conducted by the E. coli 
maltose transporter system. According to the literature, the binding affinity between the 
isolated MalF-P2 and MBP (about 10-20 μM) is similar to the Km of the MBP-stimulated 
ATPase of the wild-type maltose transporter, MalFGK2 (27, 47). The significance of P2 
in recruiting MBP is also supported by the EPR results of MBP E274C (Chapter 3). Thus 
a rational explanation for the dysfunction of MalF(ΔP2)GK2 is that the binding affinity 
drops too low for MalF(ΔP2)GK2 to bind MBP. The following sections describe how 











substrate-stimulated ATPase can be compensated by increasing MBP concentration to 
1mM 。 
 
Table 4.1 Characterization of E. coli maltose transporter mutants. 
Strain AD126  





MalF(ΔP2)GK2, no MBP White 
MalFGK2 (wild type)+MBP Red 
MalFGK2 (wild type), no MBP White 
MalF500GK2, no MBP Red 
MalF500 (ΔP2) GK2, no MBP Red 
*
Maltose-fermenting E. coli appears as red colonies on a MacConkey Agar with 1% 
maltose, indicating a successful maltose transport into the cell. The observation was made 
after 14-hour incubation at 37   The color of the colonies of each sample is uniformly 
red or white. Observation after 12-hour incubation of MalF500 (ΔP2) GK2, no MBP 
shows smaller red in the middle of the colony with white edges, indicating a slower 
maltose metabolic rate.  
 
It is known that binding-protein independent (BPI) proteins are able to couple 
substrate transport and ATP hydrolysis in the absence of the periplasmic substrate 
binding protein. To verify whether deletion of P2 disrupts the catalytic cycle, a binding 
protein independent (BPI) mutant was introduced to the P2 truncation mutant of the 
maltose transporter and the name of this mutant is F500ΔP2GK2. Briefly, the mutations 











that BPI can transport maltose without MBP. A rational explanation of this is that the 
majority of BPI rests in a high energy intermediate conformation. 
BPI is expected to maintain maltose transport function even in the absence of P2. 
F500 contains two site-mutations (G338R and N505I). The gene of malF500 with the P2 
deleted, denoted malF500 (ΔP2) was constructed by mutagenesis. In the absence of MBP, 
F500 (ΔP2) exhibited an in vivo Mal
+
 phenotype on maltose MacConkey agar after 14-
hour incubation (Table 1). This showed that the binding-protein independent mutant, 
F500 can transport maltose without P2. In addition, comparing column 2 and 3 in Table 
4.2, it took longer for the F500 (ΔP2) colonies to completely turn red than the F500 
colonies. This indicates that the maltose transport of F500 is possibly slowed down by the 
deletion of P2 with the assumption that the expression level of F500 and F500 (ΔP2) are 
comparable. This assumption is based on similar numbers of colonies grown on the 












(A)                                                                     (B) 
                 
Figure 4.1 Maltose transporters visualized by 15% SDS-PAGE gels and Commassie 
staining. The (A) F500. Lane 1, F500. Lane 2, wild-type MalFGK2. Lane 3, Molecular 
weight markers. (B) Fractions from steps of purification of F500 ΔP2 from the membrane. 
Lane 1, total membrane. Lane 2, Solubilized membrane. Lane 3, Cobalt unbound. Lane 4, 
2 mM imidazole wash of cobalt resin. Lane 5, 5 mM imidazole wash of cobalt resin. 
Lane 6, 100 mM imidazole elution of cobalt resin. Lane 7, MalF(ΔP2)GK2. Lane 8, 
Molecular weight markers. 
 
To further verify the role of P2 using the BPI mutant in vitro, different buffers 
were used to purify F500 and F500 ΔP2 GK2. F500 was successfully purified with the 
protocol described previously in section 2.2.1. However, the pure form of F500 ΔP2 GK2 
could not be obtained (Figure 4.6). The band at the position of MalG is missing for the 
elution of F500(ΔP2) from cobalt resin, although there are bands at the right positions 
indicative of the presence of MalK and MalF500ΔP2. There are four possible reasons for 
a failure of membrane protein purification: (1) gene mutation due to some reasons like 
cell toxicity, (2) low expression level, (3) mislocation to the inclusion body, and (4) mis-
folding or aggregation. The first possibility, unexpected gene mutation, can be ruled out 











induction with 50 μM IPTG at 22 . A more rational explanation is that either the 
expression level is too low or the mutant is misfolded. 
 
4.3 Purification of MalF(ΔP2)GK2 
The protein purification protocol in Section 2.2 was modified to obtain stable and 
pure MalF(ΔP2)GK2 mutant in vitro. High purity was achieved by using DDM in a buffer 
containing 50 mM Tris-HCl and 100 mM NaCl, at pH7. Purified MalF(ΔP2)GK2 was 
first characterized on the 15% SDS-PAGE gel (Figure 4.1A). Three bands (lane 1) 
corresponding to three components of MalF(ΔP2)GK2 were observed at the right position 
with a reference of the positions of the three bands of wild-type MalFGK2 (lane 3). A 
sharp symmetrical profile of purified MalF(ΔP2)GK2 in the size-exclusion 
chromatography analysis (Figure 4.1B) suggested that MalF(ΔP2)GK2 is reconstituted as 
a complex and is well folded. To test whether the dysfunction of MalF(ΔP2)GK2 is due to 
lack of interaction with MBP, MalF(ΔP2)GK2 was stabilized in nanodiscs with optimized 
lipid:Membrane Scaffold Protein (MSP):MalFGK2 ratio to mimic the membrane 
















Figure 4.2 Purification of MalF(ΔP2)GK2. (A) MalF(ΔP2)GK2 visualized by 15% SDS-
PAGE. Lane 1, MalF(ΔP2)GK2. Lane 2, an example of an attempted purification of 
MalF(ΔP2)GK2 under a different condition but showed only one band. Lane 3, MalFGK2. 
Lane 4, Molecular weight markers. (B) The elution profile of the gel filtration column.      
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4.4 Functional Reconstitution of Nanodiscs 
As outlined in Chapter 2, the nanodisc assembly mixture consists of the DDM-
purified transporter, detergent solubilized soybean phospholipids and MSP. Previous 
literature indicated that one transporter per nanodiscs is better than two per nanodiscs 
because the former one displays higher ATPase activity, and that the MSP:MalFGK2 
ratio needs to be above 5:1 (w/w) to make the major fraction be one transporter per 
nanodiscs (39). To optimize the ATPase activity, the lipid:MSP:MalFGK2 ratios were 
varied to reconstitute the nanodiscs assembly and then characterized with size-exclusion 
chromatography, analytical ultracentrifugation as well as ATPase activity assay.  
Nanodiscs were prepared with 50:1 (w/w) lipid to MSP and with MSP to MalFGK2 
varying from 20:1 to 5:1 (w/w). The crude assembly was analyzed with size-exclusion 
chromatography (Figure 4.2 D-F). With reference to the elution volumes of standard 
proteins with known molecular weight described in section 2.5, the component that 
contains one transporter per nanodisc appears to be the major symmetric peak eluted 
around 1.4 mL in the size-exclusion chromatography profile (Figure 4.2). The shoulders 
between 1.0~1.1 mL and around 1.6 mL are larger-size aggregation and smaller-size 
impurities, respectively. At either 10:1 or 20:1, the aggregation is minimal. As the 
MSP:MalFGK2 ratio increases, the smaller-size impurities increases. A rational 
interpretation was that as the ratio of MSP: MalFGK2 increases, the amount of empty 
nanodiscs with only MSP and lipid increases. Following affinity purification (Figure 4.2 
(A) - (C)) the peaks are more symmetric but the yields are much lower than the crude 











empty nanodiscs. To maintain yield and save proteins, we prefer to use the crude 
assembly instead of purifying the nanodiscs with affinity chromatography. 
 
 
Figure 4.3 Nanodiscs size-exclusion profile with different MSP:MalFGK2 ratios. (A) 
MSP:MalFGK2=5, nanodiscs were purified with Ni affinity column; (B) 
MSP:MalFGK2=10, nanodiscs were purified with Ni affinity column; (C) 
MSP:MalFGK2=20, nanodiscs were purified with Ni affinity column; (D) 
MSP:MalFGK2= 5, nanodiscs were the crude assembly that were not purified with Ni 
affinity column; (E) MSP:MalFGK2=10, nanodiscs were the crude assembly; (F) 
MSP:MalFGK2= 20, nanodiscs were the crude assembly. MalFGK2 concentration was 
approximately 6 μM. The lipid:MSP ratio was 50:1. 
   
Previous literature showed that the ATPase activities of the nanodiscs varied less 
than 40% in the 50:1 to 120:1 (w/w) lipid:MSP range (39). In this study, a broader range 
of lipid:MSP ratio was investigated, from 500 to 5, corresponding to 2500 to 25 
lipid:MalFGK2. The functional reconstitution was evaluated by ATPase activity (Figure 
4.3). Both the lipid:MalFGK2 ratios of 250:1 and 500:1 showed high MBP-stimulated 
ATPase activity. Moreover, their low ATPase activity in the absence of maltose or MBP 



































Figure 4.4 ATPase activity of nanodiscs with different lipid:MalFGK2 ratios. Top, 
ATPase activity in the presence (black) or absence (red) of 5 μM MBP; bottom, ATPase 
activity in the presence (black) or absence (red) of 100 μM maltose. 6 μM MalFGK2 were 
used in the assay. MSP: MalFGK2 equaled to 5 for the samples in the presence of MSP. 
The number labeled at the bottom of each column indicates the ratio of lipid: MalFGK2. 
The label “MalFGK2” at the bottom of the columns means that MalFGK2 was stabilized 


















































































To verify that the dominant component of the nanodiscs reconstituted are in the 
form of one transporter per two MSP, the major peak fraction of the nanodiscs in the 
size-exclusion chromatography profile was collected and concentrated to approximately 6 
uM. The samples were analyzed by our collaborator Dr. Paul Lake with analytical 
ultracentrifugation. The ratio of lipid: MalFGK2:MSP was fine-tuned according to the 
AUC profile of impurities and desired product intensity, among which the ratio of 
lipid:MSP:MalFGK2 = 500:10:1 displayed the cleanest profile with two sharp major 
peaks (Figure 4.4). The two major peaks in the AUC profile corresponded to 
sedimentation coefficient 3.3 S and 9.4 S, respectively. The molecular weights of the two 
components are estimated to be 41 kDa and 204 kDa, respectively. Thus the left peak in 
Figure 4.4 represents MBP (43 kDa). The most likely interpretation of the right peak is 
the nanodiscs with one transporter (171 kDa) per two MSP (28 kDa). The molecular 
weight estimated from the sedimentration coefficient would be too small to represent two 
transporters per two MSP. No obvious higher order aggregates or smaller-size impurities 
were shown, indicating a successful optimization of the protocol to reconstitute one 
transporter with two MSP.  
This section showed that lipid:MSP ratio falling in between 50-100:1 and 
MSP:maltose transporter ratio ranging from 5:1 to 10:1 are able to maximize the 
component of nanodiscs containing one transporter per two MSP and to maintain high 
level of MBP stimulated ATPase activity. Based on these results, lipid:MSP:maltose 
transporter = 100:5:1 was chosen to test whether increasing concentration of MBP up to 












Figure 4.5 AUC profile of MalFGK2 nanodiscs with and without maltose. 
            
4.5 ATPase Activity of MalF(ΔP2)GK2 in Nanodiscs 
From the previous two sections, the pure protein of MalF(ΔP2)GK2 was obtained in 
vitro and the functional nanodiscs reconstitution protocol with wild-type MalFGK2 was 
optimized. The binding affinity of MalF(ΔP2)GK2 and MBP is too low to be measured 
directly. To verify that the dysfunction of the transporter by the truncation of P2 was due 
to the decrease of binding affinity with MBP, MalF(ΔP2)GK2 was reconstituted into 
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Figure 4.6 ATPase activity assay of MBP-
MalF(ΔP2)GK2. (A) Binding curve of 
MBP with maltose showing the 
dissociation constant of MBP with 
maltose to be 2.1 ±0.2 μM. (B) The ability 
of MBP to stimulate the wild-type 
MalFGK2 ATPase, at MBP concentrations 
from 0 to 30 μM was measured in the 
presence of 150 μM maltose at    . The 
datapoints were fitted with the Michaelis-
Menten equation. (C) The ATPase activity 
of the wild-type maltose transporter 
stabilized in nanodiscs was measured in 
the presence of 150 μM maltose and in the 
absence or presence of 10 μM MBP at 
22   and the ATPase activities were 
shown in columns. (D) The ATPase 
acitivity of the MalF(ΔP2)GK2 stabilized 
in nanodiscs with a gradient amount of 
MBP ranging from 0 to 1 mM were 
measured in triplicates       . The assay 
was conducted in the presence of 150 μM 
maltose. Both the wild-type transporter 
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If recruiting MBP to the transporter is the sole role of P2, MBP-stimulation of 
ATPase should have displayed a Michaelis-Menten curve, the slope of which increased 
as the concentration MBP increased before saturation. The ATPase activity of 
MalF(ΔP2)GK2 stabilized in nanodiscs with MBP ranging from 100 μM to 1 mM was 
measured in the presence of 150 μM maltose and 1.5 mM ATP at 22  (Figure 4.5D). 
The solubility of MBP in water is estimated to be about 5 mM. In addition, MBP 
increases the viscosity of the solution, thus making it hard to add high concentrations of 
MBP and mix the reagents in the solution. A MBP concentration of 1 mM is 
approximately the upper limit that can be used in the ATPase activity assay.  
The ATPase activity of MalF(ΔP2)GK2 in the presence of 1 mM MBP (57.7 
nmol/mg/min) is less than 10% higher than that in the absence of MBP (52.7 
nmol/mg/min) (Figure 4.5D). If this is explained by the fact that the Km for 
MalF(ΔP2)GK2 is much higher than 1094 μM, the ATPase activity should still increase 
as the concentration of MBP increases from 0 to 1 mM, since the amount of MBP bound 
to the transporter increases as the amount of MBP increases before saturation. However, 
instead of a positive correlation between the ATPase activity and the concentration of 
MBP before saturation, the curve of the ATPase activity of MalF(ΔP2)GK2 versus MBP 
concentration was flat. This indicated that the function of maltose transport is disabled by 
the deletion of P2. Regardless of no increase in the ATPase activity, MalF(ΔP2)GK2 still 
displays an absolute value of 50 ~ 60 nmol/min/mg ATPase activity, suggesting that 
MalK dimer is still an active ATPase after truncation of P2. 
As a control of MBP stimulation, the ability of MBP to stimulate the wild-type 











2.5 to 27 μM was measured in the presence of 150 μM maltose and 1.5 mM ATP at 37  
(Figure 4.5B). The curve fits to the Michaelis-Menten equation which yielded Km value 
of approximately 7 uM, consistent with the reported Km value of about 15 uM (27). The 
nanodiscs reconstitution and the assay conditions were controlled by the wild-type 
maltose transporter nanodiscs. The ATPase activity of MalFGK2 was 1949.1 
nmol/mg/min in the presence of 10 μM MBP and 43.7 nmol/min/mg in the absence of 
MBP(Figure 4.5B), displaying a MBP-stimulation of about 45-fold, consistent with the 
literature (27). In addition, the background reading from MBP and the reagents for the 
ATPase activity assay was negligible.  
To verify that the maltose concentration in the ATPase assay is abundant for MBP, 
the dissociation constant (Kd) of MBP with Maltose was determined by intrinsic 
fluorescence (Figure 4.5A) to be 2.11±0.22 μ M. This is consistent with the reported Kd 
(3 μ M) (48, 50). Thus, 150 μM maltose in the ATPase activity assay is abundant for 
MBP.  
In summary, P2 loop deletion disrupted the MBP stimulation of ATPase activity of 
the maltose transporter complex, and it cannot be rescued by increasing maltose-MBP 
concentration up to 1mM. 
 
4.6 Discussion  
To test functions of P2, a mutant which has a replacement of P2 with a short GSGSG 
linker, MalF(ΔP2)GK2 was purified and characterized. Before testing ATPase activity 
assay with MalF(ΔP2)GK2 in nanodiscs, we optimized the functional reconstitution of the 











MSP:MalFGK2 ratio should be 5:1 in order to minimize the amount of aggregation and 
empty nanodiscs in the crude nanodiscs. Lipid: MalFGK2 should be 50~100:1 to maintain 
a high MBP-stimulated ATPase activity of MalFGK2. The nanodiscs were demonstrated 
to contain one MalFGK2 per two MSP by the sedimentation coefficient of the assembly. 
In agreement with the ability of MalF(ΔP2)GK2 to be co-crystalized with EIIA
Glc
, 
our results suggest that the MalF(ΔP2)GK2 is well-folded.
 
However, the function of 
MalFGK2 was disabled by the deletion of P2 (Table 4.1). Wild-type MalFGK2 reaches 
the maximal ATPase activity with only 20-25 μM MBP. However, no MBP-stimulated 
ATPase activity of MalF(ΔP2)GK2 was detected even in the presence of 1 mM MBP 
(Figure 4.5). This may due to the increase in Km to such an extent that 1 mM MBP 
cannot bind MalF(ΔP2)GK2. Nevetheless, this study indicated that MalFGK2 cannot 
interact with MBP in the absence of P2. And it suggested a possible role of the 
interaction between P2 and MBP in inducing or stabilizing a high-energy intermediate 
conformation of the maltose transporter between resting state and transition state. To 
further test which steps in maltose transport catalytic cycle the interaction of P2 and MBP 
are responsible for, we constructed a P2-deleted mutant on F500.  
Binding-protein independent proteins, however, do not need MBP to transport 
maltose into the cell (section 1.5). A rational explanation for the independence of MBP 
for our study is that the resting state of BPI is distablized and that the majority of the BPI 
mutant rests in a high-energy intermediate that can easily proceed to the out-ward facing 
transition state conformation without the assistance of MBP (19, 25, 36),  Based on this 
assumption, we hypothesized that F500 is able to transport maltose without P2, which 











from Dr. Shanshuang Chen revealed that the maltose transporter is able to function when 
it is crosslinked with MBP whereas lowering the local concentration of MBP by breaking 
the disulfide bond between MBP and the transporter with DTT reduced ATPase activity 
(24). Together with our finding that the MBP-P2 interaction is maintained throughout the 
catalytic cycle and that F500 can function after P2 truncation, it is likely that P2 is only 
involved in recruiting MBP. 
Recent NMR studies have shown that the binding of P2 induces a semi-open state of 
MBP both in the presence and absence of maltose (49). Conflicting results are found in 
the pre-T state crystal structure in which MBP is not semi-open (19).  This discrepancy 
may due to the lack of interactions between MBP and other extracytoplasmic loops of 
MalFG when using an isolated P2. Nevertheless, the possibility that MBP-P2 interaction 
contributes to the conformational change from the resting state to the transition state 
cannot be completely ruled out. 
To conclude, chapter 4 mainly reported that P2 truncation in wild-type results in 
loss of function whereas P2 domain is not essential for BPI mutant F500. It is possible 
that MBP-P2 interaction is significant in the conformational change from resting state to 
a high-energy intermediate, although no communication between 1 mM MBP and MalK 
might due to too low binding affinity of MalF(ΔP2)GK2 to bind with MBP.  
The current maltose transport model was modified based on the results in the thesis 
(Figure 4.7). MalF-P2 maintains close contact with MBP N-lobe throughout the cycle. 
Upon the addition of maltose, interaction between MalG short loops and MBP N-lobe 
becomes much stronger while interaction between MalF short loops and MBP C-lobe 












Figure 4.7 A Model of the E.coli maltose transporter catalytic cycle. The interaction 
between MBP and MalFG in the inward-facing conformation and in the intermediate 
conformations between inward-facing and outward-facing conformations are modified 
according to our results and the reported model (19). MBP N-lobe initially interacts with 
MalF-P2 even in the absence of maltose. Maltose triggers MBP closure and enhance the 
interaction between MBP N-lobe and MalG, while MBP C-lobe remains in equilibrium 
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APPENDIX INHIBITION OF MALTOSE UPTAKE 
A.1 Introduction 
The maltose transporter from Streptococcus pneumonia is crucial to survival of the 
organism in the human host.  Therefore, inhibitors of maltose uptake could, in theory, 
would prevent infection (51). Based on the crystal structure of MalEFGK2, which reveals 
the mode of interaction between maltodextrins and the two maltose-binding sites in the 
transporter, we propose that modifications at the non-reducing end of a maltodextrin 
might allow binding to MBP but prevent binding to MalF in the membrane.  A mutation 
in the MalF binding site (G380D) that prevented maltose binding resulted in uncoupling 
of ATP hydrolysis from maltose transport (48), and suggested that a similar modification 
of the sugar substrate might result in the consumption of ATP while inhibiting 
maltodextrin (nutrient) uptake, leading to the death of the bacteria. The St. pneumonia 
maltose transporter is a member of the ATP-binding cassette superfamily, bearing 
similarity to the E. coli maltose transporter. We plan to test our hypothesis in the better 
characterized maltose system before working with S. pneumonia.  
In collaboration with the group of Dr. Alexander Wei at Purdue University, we 
designed and chemically synthesized a molecule, named gal-glu4. It consists of one 
lactose unit and one maltotriose unit (Figure 1). The reducing end of this drug mimics 
maltose and is supposed to bind with the maltose binding site of MBP (52). But unlike 










MalFG, the non-reducing end of this drug has a beta connection that is expected to be 
unable to bind MalFG. Our lab has found (data not published) that gal-glu4, like maltose, 
can stimulate ATPase activity of the E. coli maltose transporter. We hypothesize that gal-
glu4 binds MBP and stimulates but fails to be transported may preferentially be bound by 
MBP and keep consuming ATP. If this is the case, the bacteria will be killed. A question 
of interest is whether a non-transported sugar analogue will be more effective as an 
inhibitor of maltose transport than one that is transported, such as maltotriose.  
One method for testing our hypothesis is to determine whether lower 
concentrations of gal-glu4 are able to compete effectively for binding. In vitro maltose 
uptake assay was also conducted to evaluate maltose uptake inhibition by the drug.  
 
 












Preparation of proteoliposomes is needed to mimic the natural environment in 
which the maltose transporter complex is stabilized in membrane and the uptake of 
maltose is from outside to the inside of the lipid vesicle. Proteoliposomes are prepared 
following the description in (33). 
H
3
-Maltose Transport Assay. The ratio of lipid: MalFGK2 in the proteoliposome 
was 100:1 (w/w). The protein concentration was determined to be about 0.80 mg/ml with 
an Amido Black assay. 35mM ATP and 20mM MgCl2 were added to the suspension 
buffer and the PLV was flash frozen with dry ice and slowly thawed in the ice-water bath 
6 times and then sonicated 10s on/off for 3 times until it became transparent. For the 
transport assay, I used 2 μM 200 μCi/L H3-maltose. 25ul of the sample was loaded at 
each time point onto the filter which connected to a pump. The filters were rinsed, dried 




    Figure 2 shows the dissociation constant (Kd) of maltose is 2.11±0.22 μ M and the 












Figure A.2 Binding Curve and Binding Affinity of MBP with gal-glu4 (left) and maltose 
(right). 
 
The result of the in Vitro Maltose Transport Assay with Proteoliposomes is shown 
in Figure 3. Maltose uptake is saturated within 30s when MBP is 1 or 2 μ M while the 
one of the 0.5 μ M MBP group continued to take up maltose for 70 seconds. The maltose 
uptake saturation amount appears similar for 0.5 to 2 μ M MBP. The result indicates that 
using lower amounts of MBP slows down the rate of maltose uptake while maintaining 
the maximum amount of maltose that can be taken up. Therefore, 0.5uM MBP is used for 












Figure A.3 Maltose Uptake Assay with 0.5 (blue), 1 (red), and 2 (green) μM MBP, and 
MalFGK2 reconstituted in proteoliposomes. 
   
The initial maltose uptake rates of the maltose transporter reconstituted in 
proteoliposomes are listed in Table 1. The initial uptake rates of the samples in the 
presence of gal-glu4 are lower than those without gal-glu4. However, the error of the 
duplicate uptake initial rates of maltose transporter in the presence of 2 μM maltose and 1 
μM MBP is as large as about 10 fold (0.00898 versus 0.00097 nmol/mg/s). The assay was 
attempted to be reproduced and the results are shown in Table 2. But the errors between 





y = 0.0317x + 0.4433 
R² = 0.9029 
y = 0.1167x + 0.3484 
R² = 0.8833 
y = 0.0791x + 0.4322 









































-Maltose uptake assay initial rate in the presence of gal-glu4 
 Initial Rate  R
2 
2 μ M maltose, 0.5 μ M MBP 0.0162 0.9927 
2 μ M maltose, 1 μ M MBP 0.0898 1 
2 μ M maltose, 1 μ M MBP (Duplicate) 0.0097  0.7273 
2 μ M maltose, 0.5 μ M MBP, 1 μ M gal-
glu4 
0.0079 0.9983 
2 μ M maltose, 1 μ M MBP, 2 μ M gal-
glu4 
0.0078 0.9708 
The unit of initial rate in the table is nmol/mg/s. The R
2
 written as “1” was because only 




-Maltose uptake assay initial rate in the presence of gal-glu3, gal-glu4 or 
maltotriose 
 Duplicate 1 Duplicate 2 Average 




2 μ M maltose 0.031 1 0.0117 1 0.0214 
2 μ M maltose  
+ 1 μ M gal-glu4 
0.0034 1 0.0046 0.9768 0.0040 
2 μ M maltose  
+ 2 μ M gal-glu4 
0.0056 0.9071 0.0072 0.8593 0.0064 
2 μ M maltose 
+  4 μ M gal-glu4 
0.0036 0.8660 0.0067 0.9789 0.0052 
2 μ M maltose  
+ 20 μ M gal-glu3 
0.0065 0.9788 ND ND 0.0065 
2 μ M maltotriose 0.0066 0.9582 ND ND 0.0066 










In this assay, 2uM 
3
H maltose and 1uM MBP are present in each sample. The unit of the 
initial rate is nmol/mg/s.  ND: not determined. The R
2
 written as “1” was because only 
two data points are plotted before saturation in 30s. 
 
A.4 Discussion 
The reported Kd for maltotriose binding to MBP is 0.16 μM (42), much lower than 
that of maltose. Our results are consistent with this low dissociation constant by showing 
a bigger initial uptake rate in the presence of 2 μM maltotriose and 2 μM maltose than in 
the presence of 2 μM maltose alone. More experiments will be needed to determine the 
Ki for maltotriose.  
In comparison of the row 2 and row 5 in Table 1, the maltose uptake initial rate in 
the presence of only 1 μM gal-glu4 is 10 times lower than that without gal-glu4. We 
would be excited if this result is reproducible. However, the errors between the duplicates 
undermine firm conclusions about the inhibition effectiveness of gal-glu4. Unfortunately, 

























Yan Huang was born on August 27, 1988, in Jinan, Shandong Province, China. 
Her grandpa, an excellent architect, impressed her by the passion and perseverance to 
science. Her grandma, a farmer and worker, taught her to work hard and love people 
generously. She was enrolled by Dept. of International Studies, Zhejiang University in 
2006. The resource crisis and pollutions in China drove her to switch major from English 
to Environmental Science in 2008. She developed an interest in doing research during 
working in the Xu laboratory in her sophomore and junior years. The summer research 
experience in Dr. Karen McDonald’s laboratory at UC Davis made her determined to 
studying biotechnology oversea. She fell in love with Hang Yu at Zhejiang University 
and keeps a long-distance relationship with him since then. She became a PhD candidate 
at Purdue University in December 2012. The sad news that her advisor, Dr. Amy L. 
Davidson died of cancer did not stop her from pursuing excellence, in the memory of 
such a great advisor and scientist. Now she is ready to face the new challenges of 
studying developmental biology in Dr. Umulis’ group. 
          60 
